Moderna is facing a new, potentially costly legal battle from competitor CureVac over key RNA production methods for its Spikevax vaccine. This adds to legal risks and potential future liabilities following the recent Arbutus settlement.
Filing excerpt
In April 2026, CureVac SE and CureVac Manufacturing GmbH filed a complaint against us in the U.S. District Court for the District of Delaware asserting that our manufacture and sale of Spikevax willfully infringes U.S. patents directed to RNA production methods and compositions with RNA encoding modified SARS-CoV-2 spike protein.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Regions named
sec-10qlitigationMaterialGet every 10-Q signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/ad14f0a2-a9de-47ef-a84a-dc42739b8148 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "ad14f0a2-a9de-47ef-a84a-dc42739b8148",
"signal_type": "sec-10q",
"signal_subtype": "litigationMaterial",
"detected_at": "2026-05-05T08:48:22.452+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "Moderna is facing a new, potentially costly legal battle from competitor CureVac over key RNA production methods for its Spikevax vaccine. This adds to legal risks and potential future liabilities following the recent Arbutus settlement.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Unspecified damages sought"
},
"summary": "CureVac filed new patent infringement lawsuit in April 2026 over Spikevax vaccine.",
"excerpts": "In April 2026, CureVac SE and CureVac Manufacturing GmbH filed a complaint against us in the U.S. District Court for the District of Delaware asserting that our manufacture and sale of Spikevax willfully infringes U.S. patents directed to RNA production methods and compositions with RNA encoding modified SARS-CoV-2 spike protein.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000060/mrna-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Legal tech opportunity",
"signal_category": "risk",
"regions_mentioned": [
"US"
],
"competitors_mentioned": [
"CureVac SE",
"CureVac Manufacturing GmbH"
]
}
}
curl https://signals.autobound.ai/v1/signals/ad14f0a2-a9de-47ef-a84a-dc42739b8148 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.